ArticleScientific data2026
Persistent hindrances to data re-use in single-cell genomics.
Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Persistent hindrances to data re-use in single-cell genomics.Scientific data · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
We evaluated the reusability of publicly available single-cell RNA-sequencing studies (scRNA-seq) from the Gene Expression Omnibus, focusing on the prevalent 10x Genomics-based datasets. Through semi-automated and manual curation, we assessed the availability of cell-level expression count matrices and cell-type annotations. Only around 40% of studies provided readily usable processed count data that could be reliably mapped to GEO metadata, and fewer than 10% included author-provided cell-type labels. Although most studies had raw sequencing files available, few could be re-analyzed automatically without reliance on heuristics. Our findings show that existing practices for scRNA-seq data distribution and sharing are insufficient for effective reuse, and highlight the urgent need for repositories to strengthen and enforce submission requirements, particularly for processed data and cell-type annotations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.